Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease
Kun Yang, … , Luis A. Garza, Nan Yan
Kun Yang, … , Luis A. Garza, Nan Yan
Published January 18, 2022
Citation Information: J Clin Invest. 2022;132(2):e146176. https://doi.org/10.1172/JCI146176.
View: Text | PDF
Research Article Autoimmunity Metabolism

Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease

  • Text
  • PDF
Abstract

Inborn errors of nucleic acid metabolism often cause aberrant activation of nucleic acid sensing pathways, leading to autoimmune or autoinflammatory diseases. The SKIV2L RNA exosome is cytoplasmic RNA degradation machinery that was thought to be essential for preventing the self-RNA–mediated interferon (IFN) response. Here, we demonstrate the physiological function of SKIV2L in mammals. We found that Skiv2l deficiency in mice disrupted epidermal and T cell homeostasis in a cell-intrinsic manner independently of IFN. Skiv2l-deficient mice developed skin inflammation and hair abnormality, which were also observed in a SKIV2L-deficient patient. Epidermis-specific deletion of Skiv2l caused hyperproliferation of keratinocytes and disrupted epidermal stratification, leading to impaired skin barrier with no appreciable IFN activation. Moreover, Skiv2l-deficient T cells were chronically hyperactivated and these T cells attacked lesional skin as well as hair follicles. Mechanistically, SKIV2L loss activated the mTORC1 pathway in both keratinocytes and T cells. Both systemic and topical rapamycin treatment of Skiv2l-deficient mice ameliorated epidermal hyperplasia and skin inflammation. Together, we demonstrate that mTORC1, a classical nutrient sensor, also senses cytoplasmic RNA quality control failure and drives autoinflammatory disease. We also propose SKIV2L-associated trichohepatoenteric syndrome (THES) as a new mTORopathy for which sirolimus may be a promising therapy.

Authors

Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan

×

Figure 7

Activation of the mTORC1 pathway in skin tissue from the patient with THES2.

Options: View larger image (or click on image) Download as PowerPoint
Activation of the mTORC1 pathway in skin tissue from the patient with TH...
(A) Western blot analysis of SKIV2L and TTC37 in skin-derived fibroblasts from a patient with THES2 carrying SKIV2L mutations and a healthy control. (B) Images showing hair abnormalities (so-called woolly hair appearance) and erythematous raised nonpruritic rash of patient with SKIV2L. (C) H&E staining of skin biopsy from the patient with THES2 indicates interface dermatitis. Dashed line, epidermal-dermal junction. (D) Interferon score of PBMCs from the patient with THES2 and 2 healthy controls. (E) Fluorescence immunohistochemistry analysis of p-S6 ribosomal protein (S235/236) and K14 in skin biopsies from healthy controls, the patient with THES2, and an unrelated case of AD. Dashed line, epidermal-dermal junction. Scale bar: 100 μm. (F) A schematic model for how Skiv2l-deficiency causes mTORC1 activation and disruption to both epidermal and T cell immune homeostasis leading to autoinflammatory skin disease.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts